Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel for slow flow/no-reflow during PCI in acute coronary syndrome
ChiCTR-TRC-13003923Phase 4Completed
- Sponsor
- Department of Cardiology, Zhujiang Hospital
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor and clopidogrel in acute coronary syndrome (ACS) (2 arms), sponsored by Department of Cardiology, Zhujiang Hospital. Primary endpoint: Slow flow / no-reflow incidence. Started Mar 2013; status: completed.
02
Drugs
ticagrelorclopidogrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-TRC-13003923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003923.